Levetiracetam
- Product NDC
- 70860-602
- 11-digit product format
- 708600602
- Labeler code
- 70860
- Product ID
- 70860-602_54cfc4a8-72a1-4d15-b787-e90f87d663c4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA206880
- Marketing category
- ANDA
- Marketing start
- 2018-05-30
- Marketing end
- 0000-00-00
- Substance
- LEVETIRACETAM
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-602 | LEVETIRACETAM INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 6 | Legacy NDC | 20250514_da023a3c-e4c7-49a3-968e-9ae33ea7feda.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-602-82 | 70860060282 | 10 POUCH in 1 CARTON (70860-602-82) > 1 BAG in 1 POUCH (70860-602-41) > 100 mL in 1 BAG | 10 pouch | 2018-05-30 | 0000-00-00 | No | No | Current |